Allergen, Individual-Food Cheese Cheddar F81

The Allergen, Individual-Food Cheese Cheddar F81 is a targeted at‑home allergy test designed to detect IgE sensitization to proteins commonly found in cheddar cheese. Using a small capillary blood sample collected with the supplied finger‑prick kit, the sample is sent to a certified laboratory for quantitative measurement of specific IgE antibodies to cheddar-related proteins; this helps determine immune sensitization that can trigger allergic reactions.

This test is suitable for Dubai residents who experience immediate or recurrent symptoms after consuming cheddar or other dairy products—such as hives, swelling, wheeze, vomiting, or gastrointestinal upset—or for those who need objective confirmation before reintroducing cheese into the diet. Results include lab-validated values and an explanatory report to guide avoidance strategies; positive results indicate sensitization and should be interpreted alongside clinical history by a UAE physician or allergist to confirm true clinical allergy and plan management.

• Cheddar cheese-specific IgE
• Casein-specific IgE (milk protein)
• Beta-lactoglobulin-specific IgE
• Total IgE (where applicable)

• Immediate allergic symptoms after eating cheddar (hives, swelling, breathing difficulty)
• Recurrent gastrointestinal symptoms linked to cheese consumption
• Unexplained eczema or chronic urticaria worsened by dairy
• Before reintroducing cheese following an elimination diet
• When a clinician suspects IgE‑mediated dairy allergy and needs objective confirmation

• At‑home capillary blood collection with professional laboratory analysis
• Quantitative measurement of cheddar and related milk-protein IgE
• Fast, lab-validated results with a clear explanatory report
• Practical dietary avoidance guidance and next-step recommendations
• Facilitates follow-up with UAE clinicians and allergy specialists

• At‑home capillary (finger‑prick) blood sample collection using the provided kit
• No fasting required prior to sample collection
• Inform provider about recent anti‑IgE therapy (e.g., omalizumab) or recent severe allergic reactions
• Suitable for adults and children—follow kit age instructions and seek pediatrician guidance for infants